LETTER
We wish to draw attention to the increased frequency of ACE I/D (angiotensin converting enzyme insertion/deletion) polymorphisms in type 2 diabetic patients in the Gujurat region of India. The gene-encoding ACE is located on chromosome 17q23 and known to show I/D polymorphism of a 287 bp Alu-1-repetitive sequence (NCBI: AF118569; repeat region 14094-14381) in intron 16. This accounts for half of the variance of serum ACE levels in individuals homozygous for the insertion allele (II genotype) who have lower ACE levels than carriers of the deletion allele (ID and DD genotypes). 1 Association studies of ACE I/D polymorphisms in people with type 2 diabetes of different ethnicities have yielded conflicting results, 2 so we undertook a case control study to investigate the association of ACE I/D polymorphism with type 2 diabetes in subjects from Gujarat.
Genomic DNA was isolated from whole blood of 290 (132 males and 158 females) type 2 diabetic patients (fasting blood glucose >180 mg/dl) and 445 (205 males and 240 females) ethnically matched non-diabetic individuals. The ACE I/D polymorphism was genotyped and scored by polymerase chain reaction (PCR). 3 Significant differences in the genotype frequencies of I/I, I/D and D/D genotypes were observed between diabetic and nondiabetic subjects (p=0.001) suggesting an association of the ACE I/D polymorphism with type 2 diabetes. The allele frequencies for I and D alleles also differed significantly between diabetic and non-diabetic subjects (p=0.001). The type 2 diabetic population deviated from the Hardy-Weinberg equilibrium for the polymorphism (p=0.0001) and the non-diabetic population followed genetic equilibrium (p=0.102) (table 1) .
A recent meta-analysis of ACE I/D polymorphism in type 2 diabetic showed significant association with the D allele in those of Caucasian and East Asian ethnicities. 2 Our study in the ACE gene I/D polymorphism in type 2 diabetes: the Gujarat population 
